IP Library Granted Patent US 11,311,666
Granted Patent B1
US 11,311,666 · App. 17/178,782 · Granted Apr 26, 2022

Modular wearable medicament delivery device and method of use thereof

Inventors: Sharon D. West (Elkins Park, PA); Justin E. Bechstein (Philadelphia, PA)
Assignee: Fresenius Kabi Deutschland GmbH
A61M5/14248A61M2005/14252A61M2230/201A61M2230/208A61M2230/30A61M2230/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,311,666
App. No.
17/178,782
Granted
Apr 26, 2022
Kind
B1
Abstract

A medicament delivery device and method of use thereof. The device includes a sensor module and an injector module. The injector module is adapted to (i) be coupled to the sensor module during injection of a cannula and a needle into subcutaneous tissue and during delivery of the medicament and (ii) be removed from the sensor module after the delivery of the medicament.

Claims (62)

1. A medicament delivery device comprising:

a sensor module comprising:

a sensor housing,

at least one sensor disposed in the sensor housing, and

an adhesive patch adapted for connecting the sensor module to a skin surface; and

an injector module comprising:

an injector module housing,

a reservoir disposed in the injector module housing, the reservoir adapted to be filled with a medicament to be delivered to a patient,

a cannula adapted to (i) fluidically connect with the reservoir and (ii) pass into a subcutaneous tissue,

a needle initially disposed in a lumen defined by the cannula and adapted to pass into the subcutaneous tissue, and

a coupling mechanism adapted to couple the injector module to the sensor module, the coupling mechanism comprising a latch,

wherein the injector module is adapted to (i) be coupled to the sensor module during injection of the cannula and the needle into the subcutaneous tissue and during delivery of the medicament and (ii) be removed from the sensor module after the delivery of the medicament.

2. The medicament delivery device of claim 1 , wherein the at least one sensor comprises at least one of a temperature sensor, an accelerometer, a gyroscope, a pulse oximeter, a blood pressure sensor, a hydration sensor, a pH sensor, glucose sensor, or a UV exposure sensor.

3. The medicament delivery device of claim 1 , wherein the at least one sensor is disposed on a bottom surface of the sensor module and is configured to be in contact with the skin surface when the adhesive patch is connected thereto.

4. The medicament delivery device of claim 1 , wherein the sensor module defines a recess adapted to mate with the latch.

5. The medicament delivery device of claim 1 , wherein the coupling mechanism comprises a push button adapted to move the latch between an engaged position and a disengaged position.

6. The medicament delivery device of claim 5 , wherein the push button extends through a portion of the injector module housing.

7. The medicament delivery device of claim 1 , wherein the sensor housing of the sensor module defines a needle port.

8. A medicament delivery device of comprising:

a sensor module comprising:

a sensor housing, the sensor housing defining a needle port,

at least one sensor disposed in the sensor housing, and

an adhesive patch adapted for connecting the sensor module to a skin surface; and

an injector module comprising:

an injector module housing,

a reservoir disposed in the injector module housing, the reservoir adapted to be filled with a medicament to be delivered to a patient,

a cannula adapted to (i) fluidically connect with the reservoir, (ii) pass into a subcutaneous tissue, and (iii) pass through the needle port of the sensor module,

a needle initially disposed in a lumen defined by the cannula and adapted to pass into the subcutaneous tissue, and

a coupling mechanism adapted to couple the injector module to the sensor module,

wherein the injector module is adapted to (i) be coupled to the sensor module during injection of the cannula and the needle into the subcutaneous tissue and during delivery of the medicament and (ii) be removed from the sensor module after the delivery of the medicament.

9. A medicament delivery device comprising:

a sensor module comprising:

a sensor housing, the sensor housing defining a needle port,

at least one sensor disposed in the sensor housing, and

an adhesive patch adapted for connecting the sensor module to a skin surface; and

an injector module comprising:

an injector module housing,

a reservoir disposed in the injector module housing, the reservoir adapted to be filled with a medicament to be delivered to a patient,

a cannula adapted to (i) fluidically connect with the reservoir and (ii) pass into a subcutaneous tissue,

a needle initially disposed in a lumen defined by the cannula and adapted to (i) pass into the subcutaneous tissue and (ii) pass through the needle port, and

a coupling mechanism adapted to couple the injector module to the sensor module,

wherein the injector module is adapted to (i) be coupled to the sensor module during injection of the cannula and the needle into the subcutaneous tissue and during delivery of the medicament and (ii) be removed from the sensor module after the delivery of the medicament.

10. A method for delivering a medicament, the method comprising:

connecting to a skin surface a medicament delivery device comprising an injector module coupled to a sensor module comprising at least one sensor, wherein (i) the injector module comprises a reservoir containing the medicament, and (ii) the injector module comprises a coupling mechanism adapted to couple the injector module to the sensor module, the coupling mechanism comprising a latch;

delivering the medicament from the injector module into a subcutaneous tissue; and

after delivery of the medicament, removing the injector module from the sensor module while leaving the sensor module in contact with the skin surface.

11. The method of claim 10 , wherein the injector module further comprises a cannula in fluidic communication with the reservoir, and delivering the medicament comprises passing the cannula into the subcutaneous tissue.

12. The method of claim 11 , further comprising leaving the cannula in the subcutaneous tissue after delivery of the medicament.

13. The method of claim 11 , wherein the injector module further comprises a needle disposed in a lumen in the cannula, and delivering the medicament comprises piercing the skin surface with the needle prior to passing the cannula into the subcutaneous tissue.

14. The method of claim 10 , further comprising monitoring a biometric parameter with the sensor module.

15. The method of claim 14 , wherein the biometric parameter is monitored after the injector module is removed.

16. The method of claim 14 , wherein the biometric parameter comprises at least one of temperature, oxygen level, blood pressure, hydration, pH, glucose, or UV exposure.

17. The method of claim 10 , wherein the sensor module defines a recess adapted to mate with the latch.

18. The method of claim 10 , wherein the coupling mechanism comprises a push button adapted to move the latch between an engaged position and a disengaged position.

19. A method for delivering a medicament, the method comprising:

connecting to a skin surface a medicament delivery device of claim 8 ;

delivering the medicament from the injector module into a subcutaneous tissue; and

after delivery of the medicament, removing the injector module from the sensor module while leaving the sensor module in contact with the skin surface.

20. A method for delivering a medicament, the method comprising:

connecting to a skin surface a medicament delivery device of claim 9 ;

delivering the medicament from the injector module into a subcutaneous tissue; and

after delivery of the medicament, removing the injector module from the sensor module while leaving the sensor module in contact with the skin surface.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME PREVIOUSLY RECORDED AT REEL: 055639 FRAME: 0544. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Mar 18, 2022
From: BRESSLERGROUP, INC.
To: FRESENIUS KABI DEUTSCHLAND GMBH
Reel/Frame 059437/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2021
From: BRESSLERGROUP, INC.
To: FRESENIUS KABI DEUTCHLAND GMBH
Reel/Frame 055639/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2021
From: WEST, SHARON D.; BECHSTEIN, JUSTIN E.
To: BRESSLERGROUP, INC.
Reel/Frame 055578/0367 →
Cited By (4)
US 1,122,440 US 12,226,613 US 12,533,298 US 12,691,213